Stock Code: 301015 Bond Code: 123194 Stock Abbreviation: Baiyang Pharmaceutical Bond Abbreviation: Baiyang Convertible Bond Announcement No.: 2026-044
Qingdao Baiyang Pharmaceutical Co., Ltd.
Announcement on Matters Related to Planning for Issuance of H Shares and Listing
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Qingdao Baiyang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the Eighth Meeting of the Fourth Board of Directors on June 10, 2026, and reviewed and approved the "Proposal on the Company's Issuance of H Shares and Listing on the Main Board of The Stock Exchange of Hong Kong Limited" and the "Proposal on the Company's H Share Issuance and Listing Plan on The Stock Exchange of Hong Kong Limited," among other related proposals. The specific details are hereby announced as follows: